Lutetium Oxodotreotide Lu-177 vs Pembrolizumab

## Lutetium Oxodotreotide Lu-177 vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Lutetium Oxodotreotide Lu-177** and **Pembrolizumab**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Lutetium Oxodotreotide Lu-177 — N/A; Pembrolizumab — 26 days.

## Chemical Properties

**Type**: Lutetium Oxodotreotide Lu-177 — Protein; Pembrolizumab — Antibody.